KOMATSU Hidetada | Central Research Laboratories, Kissei Pharmaceutical Cc., Ltd.
スポンサーリンク
概要
関連著者
-
KOMATSU Hidetada
Central Research Laboratories, Kissei Pharmaceutical Cc., Ltd.
-
Ujiie Arao
Central Research Laboratories Kissei Pharmaceutical Co. Ltd.
-
Hamano Shuichiro
Central Research Laboratories Kissei Pharmaceutical Co. Ltd.
-
KOMATSU Hidetada
Central Research Laboratories, Kissei Pharmaceutical Co., Ltd.
-
IKEDA Shigeru
Central Research Laboratories, Kissei Pharmaceutical Cc., Ltd.
-
Kojima Masami
Central Research Laboratory Kissei Pharmaceutical
-
Takehana Yasuo
Central Research Laboratory Kissei Pharmaceutical Co. Ltd.
-
Tsutsumi Naoyuki
Central Research Laboratories Kissei Pharmaceutical Co. Ltd.
-
Kusama Hiroshi
Central Research Laboratories Kissei Pharmaceutical Co. Ltd.
-
Kikuchi Shinji
Central Research Laboratory Kissei Pharmaceutical Company Ltd.
-
HAMANO Shuichiro
Central Research Laboratories, Kissei Pharmaceutical Co., Ltd.
-
UJIIE Arao
Central Research Laboratories, Kissei Pharmaceutical Co., Ltd.
-
Hiraku Seiji
Research Institute Ono Pharmaceutical Co. Ltd.
-
NAKAZAWA MASAYUKI
Central Research Laboratories, Kissei Pharmaceutical Co., Ltd.
-
Kusama Hiroshi
Central Research Laboratories, Kissei Pharmaceutical Co., Ltd.
-
Okegawa Tadao
Minase Research Institute, Ono Pharmaceutical Co., Ltd.
著作論文
- Study of the mechanism of inhibitory action of tranilast on chemical mediator release.
- Enzymatic study to characterize the slow reacting substance of anaphylaxis (SRS-A) and leukotrienes.
- Beneficial effect of OKY-046, a selective thromboxane A2 synthetase inhibitor, on experimental cerebral vasospasm.
- Inhibitory action of OKY-046HCl, a specific TXA2 synthetase inhibitor, on platelet activating factor(PAF)-induced airway hyperresponsiveness of guinea pigs: Role of TXA2 in development of PAF-induced nonspecific airway hyperresponsiveness.